Monitoring serum vancomycin concentration in children;Monitoreo clínico farmacológico de los niveles séricos de vancomicina en pacientes pediátricos

Revista de Investigacion Clinica

Volumn 55, Issue 3, 2003, Pages 276-280

  Nandí Lozano, Eugenia ^a   Ramírez López, Eduardo ^b   Ávila Figueroa, Carlos ^b  

^a Hospital del Nino Morelense   (Mexico)

^b HOSPITAL INFANTIL DE MÉXICO FEDERICO GÓMEZ   (Mexico)

Author keywords

Antibiotics farmacology; Children; Staphylococcal infections; Vancomycin

Indexed keywords

AMINOGLYCOSIDE; AMPHOTERICIN B; ANESTHETIC AGENT; ANTIBIOTIC AGENT; DIURETIC AGENT; SEDATIVE AGENT; VANCOMYCIN;

ACCURACY; ADOLESCENT; ANAPHYLAXIS; AREA UNDER THE CURVE; ARTICLE; CHILD; CONTROLLED STUDY; DATA ANALYSIS; DRUG BLOOD LEVEL; DRUG MONITORING; EPIDEMIOLOGY; FEMALE; HUMAN; IMMUNOASSAY; INFANT; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; NEPHROTOXICITY; NEWBORN; OTOTOXICITY; PHLEBITIS; POPULATION RESEARCH; REFERENCE VALUE; RETROSPECTIVE STUDY;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DRUG INTERACTIONS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; INFANT; INFANT, NEWBORN; MALE; OVERDOSE; RETROSPECTIVE STUDIES; VANCOMYCIN;

EID: 0042413753     PISSN: 00348376     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Van Wageningen AM, et al. Sequencing and analisis of genes involved in the biosynthesis of vancomycin group antibiotic. Chemestry & Biology 1998; 5(3): 155-62.
2. Baumgart S, Hall SE, Campos JM, Polin RA. Sepsis with coagulase-negative Staphylococci in critically ill newborns. Am J Dis Child 1983; 137: 461-3.
3. Schaad UB, McCracken GH, Nelson JD. Clinical pharmacology and efficacy of vancomycin in pediatric patients. J Pediatr 1980; 96: 19-26.
4. Alfred Goodman Gilman, et al. Las bases farmacológicas de la terapéutica. 8a Ed. Editorial Panamericana; 1991, p. 1102-4.
5. Rodvold Keith A, et al. Pharmacokinetics and administration regimens of vancomycin in neonates, infants and children. Clin Pharmacokinet 1997; 33(1): 32-51.
6. Schaible DH, Rocci ML, Alpert GA, Campos JM, Paul MH, Polin RA, et al. Vancomycin pharmacokinetics in infants: relationships to indices of maduration. Pediatr Infect Dis J 1986; 5(3): 304-8.
7. Hall SL. Coagulase-negative staphylococcal infections in neonates. Pediatr Infect Dis J 1991; 10: 57-67.
8. Taketomo Carol K. Pediatric dosage handbook. American Pharmaceutical Association, 6th Ed. 1999-2000.
9. Mathew P. Thomas, et al. Monitoring serum vancomycin concentrations in children: is it necesary? Pediatr Infect Dis J 1998; 17(4): 351-3.
10. Dawson SB, Trapp RG. Resumen de datos en investigación médica. En: Bioestadística médica. 3a Ed. Editorial Manual Moderno; 1999.
11. Moellering RC. Editorial: Monitoring Vancomycin Levels: Climbing the Mountain Because It is There? Clin Infect Dis 1994; 18: 544-6.
12. Cantú TG, Yamahaka-Yuen NA, Lietman PS. Serum vancomycin concentrations: reappraisal of their clinical value. Clin Infect Dis 1994; 18: 533-43.
13. Goetz MB, Sayers J. Nephrotoxicity of vancomycin and aminoglycosido theraphy separately and in combination. J Antimicrob Chemoter 1993; 32: 325-39.
14. Schaad UB, Nelson JD, McCracken GH Jr. Pharmacology and efficacy of vancomycin for staphylococcal infections in children. Rev Infect Dis 1981; 3(Suppl): 5282-8.
15. Fofah OO, Karmen A, Piscitelli J, Brim LP. Failure of prediction peak serum vancomycin concentrations from trough values in neonates. Pediatr Infect Dis J 1999; 18(3): 299-301.